↓ Skip to main content

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial

Overview of attention for article published in Cardiovascular Diabetology, October 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
Published in
Cardiovascular Diabetology, October 2020
DOI 10.1186/s12933-020-01147-9
Pubmed ID
Authors

Antonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener, Stefan Kaspers, Jyothis George, Antonio Nicolucci

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 12%
Student > Ph. D. Student 5 8%
Researcher 4 6%
Student > Master 4 6%
Student > Postgraduate 3 5%
Other 9 14%
Unknown 32 49%
Readers by discipline Count As %
Medicine and Dentistry 17 26%
Nursing and Health Professions 7 11%
Biochemistry, Genetics and Molecular Biology 4 6%
Arts and Humanities 1 2%
Agricultural and Biological Sciences 1 2%
Other 1 2%
Unknown 34 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2020.
All research outputs
#20,653,779
of 23,248,929 outputs
Outputs from Cardiovascular Diabetology
#1,254
of 1,418 outputs
Outputs of similar age
#355,156
of 415,538 outputs
Outputs of similar age from Cardiovascular Diabetology
#36
of 42 outputs
Altmetric has tracked 23,248,929 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,418 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 415,538 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.